Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ZYME | VIR |
|---|---|---|
| Price | $26.21 | $11.78 |
| Change today | ▲ 4.21% | ▲ 5.46% |
| Market cap | $1.88B | $1.99B |
| Return, 3 months | -1.9% | +14.9% |
| Return, year to date | -0.5% | +95.4% |
| Return, 1 year | +57.1% | +110.7% |
| P/E (TTM) | -13.0 | -6.7 |
| P/B | 23.4 | 2.0 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +51.9% | +78.3% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 47 | 63 |
| 30-day volatility | 48.1% | 51.0% |
| Max drawdown, 1 year | -23.6% | -25.6% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
